Endo Int'l (ENDP) Withdraws OPANA ER ANDA Following Discussion with FDA
Tweet Send to a Friend
Endo International plc (Nasdaq: ENDP) announced that based on an August 11, 2016 discussion with the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
